GENZ Biotechnology

📍 London, United Kingdom🗓 Founded 2017👥 5 employees💰 Last funded Aug 2020
Biotechnology Research🌐 genzbio.com
Website LinkedIn
Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Turkey
1
Frequently asked questions
Who invested in GENZ Biotechnology?
GENZ Biotechnology has 1 investors on record on gritt.io, 1 mid-stage.
When did GENZ Biotechnology last raise funding?
The most recent investment in GENZ Biotechnology recorded on gritt.io was in August 2020.
When was GENZ Biotechnology founded?
GENZ Biotechnology was founded in 2017.
What industry is GENZ Biotechnology in?
GENZ Biotechnology operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is GENZ Biotechnology based?
GENZ Biotechnology is headquartered in London, United Kingdom.